Mary Beard
About
In The Last Decade
Mary Beard
9 papers receiving 412 citations
Peers
Comparison fields: 5 of 55
- Oncology 265
- Molecular Biology 141
- Immunology 130
- Pulmonary and Respiratory Medicine 111
- Surgery 78
Countries citing papers authored by Mary Beard
This map shows the geographic impact of Mary Beard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Beard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Beard more than expected).
Fields of papers citing papers by Mary Beard
This network shows the impact of papers produced by Mary Beard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Beard. The network helps show where Mary Beard may publish in the future.
Co-authorship network of co-authors of Mary Beard
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Beard. A scholar is included among the top collaborators of Mary Beard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Beard. Mary Beard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 12 | |
| 3 | 9 | |
| 4 | 29 | |
| 5 | 28 | |
| 6 | 20 | |
| 7 | 135 | |
| 8 | Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer. | 37 |
| 9 | The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. | 138 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.